CONCORD BIOTECH
Back to Income Statement
|
CONCORD BIOTECH Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹261 Cr | ₹372 Cr | ₹308 Cr | ₹240 Cr | ₹175 Cr |
What is the latest Consolidated Net Profit of CONCORD BIOTECH ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹261 Cr |
| Mar2025 | ₹372 Cr |
| Mar2024 | ₹308 Cr |
| Mar2023 | ₹240 Cr |
| Mar2022 | ₹175 Cr |
How is Consolidated Net Profit of CONCORD BIOTECH Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹261 Cr | -29.80 | |
| Mar2025 | ₹372 Cr | 20.62 | |
| Mar2024 | ₹308 Cr | 28.33 | |
| Mar2023 | ₹240 Cr | 37.25 | |
| Mar2022 | ₹175 Cr | - | |
Compare Consolidated Net Profit of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,295.7 Cr | -6.1% | -19.6% | -15.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,831.0 Cr | -0.4% | -6.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,074.0 Cr | 0.9% | -3.3% | 39.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,355.0 Cr | 0.1% | -7.2% | 28.2% | Stock Analytics | |
| CIPLA | ₹107,439.0 Cr | -0.3% | -4% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,417.0 Cr | 1.5% | 3.1% | 0.4% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -6.1% |
-19.6% |
-15.9% |
| SENSEX | 0.6% |
-1.4% |
-10.7% |
You may also like the below Video Courses